DPIIT recognised startup Government of India
Startup India
Elmed Life Sciences Private Limited - pharma in Medchal Malkajgiri, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.97 Cr
▲ 48% YoY
Net profit · FY 2025
₹2.08 Cr
Net margin 12.2%
EBITDA · FY 2025
₹4 Cr
EBITDA margin 23.6%
Authorised capital
₹2.2 Cr
Registered with MCA
Paid-up capital
₹2.2 Cr
Issued & subscribed
Open charges
₹14.09 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
26
Provident fund records
About Elmed Life Sciences Private Limited
Data last updated:
Elmed Life Sciences Private Limited is a private limited company based in Medchal Malkajgiri, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2018PTC129033. Its GSTIN is 36AAFCE2980D1ZR (Telangana).
The company has an authorised share capital of ₹2.2 Cr and a paid-up capital of ₹2.2 Cr. It is led by directors Pruthivin Reddy Madduri (Managing Director) and Nikhil Konkathi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Phase – V Ida Cherlapally Kapra Mandal, Medchal Malkajgiri, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.97 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹2.08 Cr (net margin 12.2%) and EBITDA of ₹4 Cr (EBITDA margin 23.6%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 252% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Elmed Probiotics. As per MCA filings, the company has open charges of ₹14.09 Cr on record. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹35.35 Cr; the latest was in March 2026. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is JMM Formulation Private Limited with revenue of ₹17.04 Cr.
Elmed Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0017589). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elmedprobiotics.com.
Company details
CIN U24230TG2018PTC129033
Registration Number 129033
Incorporation Date 13 December 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-TS-09-0017589
Recognitions & Rankings of Elmed Life Sciences
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-09-0017589
Contact details
Elmed Life Sciences Private Limited's registered office is in Medchal Malkajgiri, Telangana. Its website is elmedprobiotics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPhase – V Ida Cherlapally Kapra Mandal, Medchal Malkajgiri, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Elmed Life Sciences Private Limited, buy the company report.
Comprehensive company report
Elmed Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Elmed Life Sciences operates one associated brand: Elmed Probiotics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Probiotic manufacturing for human, animal, and agricultural health in India. | elmedprobiotics.com |
Business activity
The main business activity of Elmed Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Elmed Life Sciences Private Limited, buy the company report.
Financials of Elmed Life Sciences Private Limited
FY 2023 filings availableElmed Life Sciences Private Limited reported revenue of ₹16.97 Cr (up 48% YoY) for FY 2025.
Revenue · FY 2025
₹16.97 Cr ▲ 48%
Net profit · FY 2025
₹2.08 Cr margin 12.2%
EBITDA · FY 2025
₹4 Cr margin 23.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 61%
5 years · compounded
▲ 252%
EBITDA CAGR growth
1 year
▲ 80%
3 years · compounded
▲ 61%
5 years · compounded
▲ 69%
Revenue has grown at a compounded annual rate (CAGR) of 252% over five years, including 48% growth in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.08 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.6% | ||||
| Net Profit Margin | 12.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elmed Life Sciences Private Limited, buy the company report.
Board of directors of Elmed Life Sciences Private Limited
Elmed Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pruthivin Reddy Madduri | Managing Director | 13 Dec 2018 | 7 Years 10 Months | Current |
| Nikhil Konkathi | Director | 13 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Elmed Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JMM Formulation Private Limited | ₹17.04 Cr (FY 2025) | 30.0% | Kala Amb, Himachal Pradesh, India | |||
| Anchor Pharma Private Limited | ₹17.02 Cr (FY 2025) | 11.0% | Daman, Daman and Diu, India | |||
| Elmed Life Sciences Private Limitedthis company | ₹16.97 Cr (FY 2025) | ₹2.08 Cr | 12.2% | 48.0% | 26 | Medchal Malkajgiri, Telangana, India |
| Dollar Co Private Limited | ₹16.91 Cr (FY 2024) | -1.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Elmed Life Sciences Private Limited, buy the company report.
Auditor
Elmed Life Sciences Private Limited is audited by GRANDHY & CO CHARTERED ACCOUNTANTS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GRANDHY & CO CHARTERED ACCOUNTANTS | FY 2023 | 001007S |
Shareholding
The shareholding of Elmed Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elmed Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14.09 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Dec 2022 | 100673095 | Hdfc Bank Limited | ₹17.08 Lakh | Open | |
| 07 Jul 2020 | 100415428 | Indian Bank | ₹9.92 Cr | Open | |
| 22 Jan 2020 | 100325296 | Indian Bank | ₹4 Cr | Open |
To see the full charge records of Elmed Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Elmed Life Sciences Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹35.35 Cr; the latest was in March 2026.
Total deals
3
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹35.35 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2026 | Funding round · Series A | ₹25.4 Cr | Investors: NABVENTURES |
| May 2021 | Funding round | ₹9.95 Cr | Investors: 3 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Elmed Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elmed Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elmed Life Sciences Private Limited has a workforce of 26 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
26
Active EPFO establishments
1
Employee growth
30%
GST
Elmed Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCE2980D1ZR | Telangana | Active | 02 Mar 2019 |
To see the full GST registrations and return filing status of Elmed Life Sciences Private Limited, buy the company report.
Recent activity
Elmed Life Sciences Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Ravinder Reddy Kommera ceased to be Director on 05 May 2019.
Charges
A charge with Indian Bank of Rs. 9.92 Cr registered on 07 Jul 2020 with Charge ID 100415428 was modified on 31 Jul 2025.
AGM
Elmed Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Elmed Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 100673095 was registered on 08 Dec 2022.
Charges
A charge with Indian Bank amounted to Rs. 9.92 Cr with Charge ID 100415428 was registered on 07 Jul 2020.
Charges
A charge with Indian Bank amounted to Rs. 4.00 Cr with Charge ID 100325296 was registered on 22 Jan 2020.
Ceased
Ravinder Reddy Kommera ceased to be Director.
Appointed
Nikhil Konkathi was appointed as Director.
Appointed
Pruthivin Reddy Madduri was appointed as Managing Director.
Appointed
Ravinder Reddy Kommera was appointed as Director.
Incorporation
13 Dec 2018
Elmed Life Sciences Private Limited was registered on 13 Dec 2018 with Roc Hyderabad & aged 7 years 10 months as per MCA records.
Frequently asked questions
Elmed Life Sciences is an active private limited company based in Medchal Malkajgiri, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 December 2018 (8+ years old) and is registered under CIN U24230TG2018PTC129033.
Elmed Life Sciences has 2 current directors:
- Pruthivin Reddy Madduri - Managing Director
- Nikhil Konkathi - Director
The latest financial statements of Elmed Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Elmed Life Sciences is 36AAFCE2980D1ZR, registered in Telangana.
The CIN (Corporate Identification Number) of Elmed Life Sciences is U24230TG2018PTC129033. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elmed Life Sciences was incorporated on 13 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Elmed Life Sciences has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹35.35 Cr; the latest was in March 2026.
The peers of Elmed Life Sciences by revenue are JMM Formulation Private Limited, Anchor Pharma Private Limited, Dollar Co Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravinder Reddy Kommera ceased to be Director on 05 May 2019. Nikhil Konkathi was appointed as Director on 13 Dec 2018. Pruthivin Reddy Madduri was appointed as Managing Director on 13 Dec 2018. Elmed Life Sciences has 4 board changes on record in total.
Yes, Elmed Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Elmed Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-TS-09-0017589).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages